Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein.
Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein. Mult Scler. 2012 Apr; 18(4):398-408.
View in:
PubMed
subject areas
Adolescent
Adolescent
Adult
Adult
Animals
Animals
Cells, Cultured
Cells, Cultured
Encephalomyelitis, Autoimmune, Experimental
Encephalomyelitis, Autoimmune, Experimental
Female
Female
Glycine
Glycine
Glycoproteins
Glycoproteins
Humans
Humans
Interferon-beta
Interferon-beta
Male
Male
Mice
Mice
Mice, Inbred C57BL
Mice, Inbred C57BL
Middle Aged
Middle Aged
Myelin-Oligodendrocyte Glycoprotein
Myelin-Oligodendrocyte Glycoprotein
Neuromyelitis Optica
Neuromyelitis Optica
Pancreatic Elastase
Pancreatic Elastase
Peptide Fragments
Peptide Fragments
Serine Proteinase Inhibitors
Serine Proteinase Inhibitors
Sulfonamides
Sulfonamides
Th1 Cells
Th1 Cells
Th17 Cells
Th17 Cells
Young Adult
Young Adult
authors with profiles
Robert Axtell